Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate

Abstract

Bafiertam showed an improved gastrointestinal tolerability profile compared with Tecfidera, with less severe GI events and fewer days of self-assessed GI symptoms, fewer GI adverse events, and lower discontinuation rates because of GI adverse events.